AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31393868
Drug: 3BNC117 and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3BNC117 and 10-1074 at 3 mg/kg every 8 weeks
Trial: 31393868
Drug: 3BNC117 and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3BNC117 and 10-1074 at 10 mg/kg every 8 weeks
Trial: 337478
Drug: Placebo infusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo infusions
Trial: 17615828
Drug: Active intervention
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active intervention PCG (children received a series of interventions including gift bags with a trainer cup, fluoride toothpaste (1450 ppm F), toothbrush, and parental advice on oral care)
Trial: 25016482
Drug: Atorvastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (10 mg daily)
Trial: 11718678
Drug: Mulberry therapy
RxNorm normalized name: MULBERRY
DrugBank: Broussonetia papyrifera pollen (DB10736)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mulberry therapy
Trial: 1628772
Drug: Glibenclamide treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glibenclamide treatment
Trial: 1672049
Drug: esmolol 1
RxNorm normalized name: esmolol 10 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: esmolol 1 mg/kg
Trial: 22463973
Drug: IV pantoprazole,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV pantoprazole, antacid, and antispasmodic
Trial: 22463973
Drug: Placebo, antacid,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, antacid, and antispasmodic (conventional group)
Trial: 18365224
Drug: 1 x
RxNorm normalized name: Black Cohosh 1 X Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 x 6 mL hylan G-F 20
Trial: 18365224
Drug: 3 x
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 x 2 mL hylan G-F 20
Trial: 18365224
Drug: 2 x
RxNorm normalized name: anti-HER2 x HER2 ADC
DrugBank: Zanidatamab zovodotin (DB15472)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 x 4 mL hylan G-F 20 (2 weeks apart)
Trial: 17229535
Drug: Bifidobacter lactis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bifidobacter lactis supplemented preterm formula (2 x 10(7) cfu/g of dry milk)
Trial: 2544742
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (LMWH) - 2,500 units 2 hours before surgery, then 5,000 units subcutaneously every morning for 9 days
Trial: 2544742
Drug: Conventional low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Conventional low-dose heparin - 5,000 units every 8 hours
Trial: 31642731
Drug: ACT-541468 25
RxNorm normalized name: ACT-541468
DrugBank: Daridorexant (DB15031)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ACT-541468 25 mg (repeated evening administration)
Trial: 24867846
Drug: Frovatriptan 2.5
RxNorm normalized name: frovatriptan 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frovatriptan 2.5 mg + dexketoprofen 25 mg (FroDex25)
Trial: 24867846
Drug: Frovatriptan 2.5
RxNorm normalized name: frovatriptan 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frovatriptan 2.5 mg + dexketoprofen 37.5 mg (FroDex37.5)
Trial: 19915475
Drug: I-gel, pLMA,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: I-gel, pLMA, cLMA
Trial: 16059992
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (1000 mg/12 h infusion followed by 1200 mg/24 h orally) and Vitamin E (600 mg/24 h)
Trial: 1387607
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose adrenaline infusion
Trial: 6469443
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg buflomedil
Trial: 6469443
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg buflomedil
Trial: 7034592
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg buflomedil
Trial: 6927816
Drug: 2000 mg
RxNorm normalized name: bran 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2000 mg piracetam
Trial: 21179732
Drug: Intravenous dripping
RxNorm normalized name: DRIP COLLECTOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous dripping of immunoglobulin for 3 months (Control)
Trial: 12016811
Drug: IVIgG (100‐300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIgG (100‐300 mg.kg‐1.d‐1) for 2‐3 days
Trial: 10907942
Drug: 30 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/day tamoxifen
Trial: 23411616
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical therapy without candesartan (n=543)
Trial: 20094823
Drug: Corticosteroid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid therapy in asthmatic patients
Trial: 19232940
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg of ephedrine per 20 mL of propofol (Group E15)
Trial: 19232940
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of ephedrine per 20 mL of propofol (Group E30)
Trial: 19232940
Drug: 1% lidocaine
RxNorm normalized name: Icy Hot Max 4%-1% Lidocaine Pain Relief Dry Topical Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% lidocaine per 20 mL of 1% propofol (Group L)
Trial: 15385385
Drug: endotracheal lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: endotracheal lidocaine 160 mg
Trial: 11427213
Drug: avasimibe 250
RxNorm normalized name: Avasimibe
DrugBank: Avasimibe (DB06442)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: avasimibe 250 mg
Trial: 11427213
Drug: avasimibe 500
RxNorm normalized name: Avasimibe
DrugBank: Avasimibe (DB06442)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: avasimibe 500 mg
Trial: 9441080
Drug: Chemotherapy (SCC)
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (SCC) regimen
Trial: 2401176
Drug: Surgery plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery plus chemotherapy
Trial: 2008945
Drug: Awake extubation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Awake extubation (either agent)
Trial: 7829769
Drug: Intravenous L-tryptophan
RxNorm normalized name: L-TRYPTOPHAN
DrugBank: Tryptophan (DB00150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous L-tryptophan (TRP)
Trial: 21366472
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of furosemide
Trial: 31371212
Drug: Cognitive Behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioural Therapy (CBT) plus placebo
Trial: 31371212
Drug: Cognitive Behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioural Therapy (CBT) plus fluoxetine (20 mg daily)
Trial: 28346003
Drug: 1% diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% diclofenac sodium cream applied topically every 12 hours for 7 days
Trial: 28346003
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream applied topically every 12 hours for 7 days
Trial: 15367427
Drug: Transfusion with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transfusion with a target dose of 1 x 10(11)/10 kg (arm B)
Trial: 6546371
Drug: Pirenzepine 25
RxNorm normalized name: pirenzepine 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirenzepine 25 mg
Trial: 30036739
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of bevacizumab, oxaliplatin and fluoropyrimidine
Trial: 22187070
Drug: Regular colonoscopy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular colonoscopy (CC)
Trial: 18552687
Drug: Protocolized Sedation
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocolized Sedation + Daily Interruption (PS + DI)
Trial: 12218525
Drug: Low-dose dexmedetomidine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dexmedetomidine (target plasma concentration 0.3 ng/ml)
Trial: 12218525
Drug: Dexmedetomidine (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (both doses) during shivering
Trial: 8725976
Drug: Cholesterol Treatment
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholesterol Treatment Program (CTP)
Trial: 1355923
Drug: Yohimbine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine (20 mg)
Trial: 31099992
Drug: RD3 (dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RD3 (dexmedetomidine at an initial dose of 0.5 μg/kg for 10 min adjusted to 0.6 μg kg−1 hr−1 throughout EIT)
Trial: 25193490
Drug: Video administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Video administered at one month (early intervention)
Trial: 25193490
Drug: Video administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Video administered at seven months (late intervention)
Trial: 22927525
Drug: Cetuximab 250
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Cetuximab 250 mg/m(2)
Trial: 22927525
Drug: Cetuximab 250
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Cetuximab 250 mg/m(2) with paclitaxel 80 mg/m(2)
Trial: 20496732
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of Fluoxetine
Trial: 17258855
Drug: Alfuzosin 10
RxNorm normalized name: Alfuzosin 10mg Oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfuzosin 10 mg OD
Trial: 12218722
Drug: E/NETA 0.25-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E/NETA 0.25-mg group
Trial: 12218722
Drug: E/NETA 0.5-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E/NETA 0.5-mg group
Trial: 7893027
Drug: Lidocaine with
RxNorm normalized name: Lidocaine with Tegaderm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine with epinephrine (0.2 mg)
Trial: 22669692
Drug: Fipronil spot-on
RxNorm normalized name: fipronil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fipronil spot-on formulation (26.8 mg a.i./kg)
Trial: 22669692
Drug: Fipronil spray
RxNorm normalized name: fipronil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fipronil spray formulation
Trial: 15730535
Drug: Topiramate (TPM)
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topiramate (TPM) 200 mg
Trial: 8542895
Drug: Talcid (hydrotalcite
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Talcid (hydrotalcite 1 g)
Trial: 8542895
Drug: Maalox (Mg‐Al‐hydroxide)
RxNorm normalized name: aluminum hydroxide / magnesium hydroxide / simethicone Oral Suspension [Maalox Plus]
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maalox (Mg‐Al‐hydroxide)
Trial: 1822599
Drug: Continuous spinal
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous spinal anesthesia (CSA) with 1.9 ml bupivacaine HCl 0.5%
Trial: 1822599
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural anesthesia (CEA) with 12.6 ml bupivacaine HCl 0.5%
Trial: 6787417
Drug: Timolol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol (10 mg twice daily)
Trial: 23864516
Drug: Delayed-treatment contact
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed-treatment contact group
Trial: 19878298
Drug: Topical treatment
RxNorm normalized name: Hongo Killer Treatment Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical treatment with calcipotriol
Trial: 18417354
Drug: Sun bed
RxNorm normalized name: CLOZAPINE (SUN)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sun bed exposure (0.5 to 1 MED, twice per week for 4 weeks)
Trial: 18417354
Drug: Daily supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily supplement of 200 IU vitamin D (cod liver oil capsules)
Trial: 12687466
Drug: Daily calcitriol
RxNorm normalized name: Calcitriol
DrugBank: Calcitriol (DB00136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daily calcitriol (10 ng/kg per day)
Trial: 12687466
Drug: Intermittent calcitriol
RxNorm normalized name: Calcitriol
DrugBank: Calcitriol (DB00136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent calcitriol (35 ng/kg twice a week)
Trial: 10227453
Drug: Oxymetholone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxymetholone (2 mg/m2/d)
Trial: 9172009
Drug: Buprenorphine (0.2‐mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (0.2‐mg sublingual tablet every 6‐8 h)
Trial: 31166287
Drug: BAK-preserved latanoprost-timolol
RxNorm normalized name: latanoprost / timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAK-preserved latanoprost-timolol fixed combination
Trial: 24313619
Drug: Porcine placental
RxNorm normalized name: Secretin porcine
DrugBank: Secretin porcine (DB09527)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Porcine placental extract (PPE), 6 capsules per day
Trial: 22967105
Drug: telbivudine 600
RxNorm normalized name: telbivudine 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: telbivudine 600 mg
Trial: 22967105
Drug: lamivudine 100
RxNorm normalized name: lamivudine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lamivudine 100 mg
Trial: 19005477
Drug: Device-guided breathing
RxNorm normalized name: cetylpyridinium chloride Mouthwash [Breath-Away]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Device-guided breathing (RESPeRATE), 15 min daily for 8 weeks
Trial: 19005477
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (regular treatment)
Trial: 16444853
Drug: Warfarin group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin group
Trial: 26026705
Drug: 24 intranasal
RxNorm normalized name: NALOXONE RESCUE KIT INTRANASAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24 intranasal units (IU) oxytocin
Trial: 24145941
Drug: Evidence based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evidence based medicine (EBM) workshop
Trial: 17485550
Drug: Real‐time quantitative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Real‐time quantitative polymerase chain reaction analysis of antigen receptor gene rearrangements for detection of minimal residual disease (MRD)
Trial: 11175930
Drug: Metered Dose
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metered Dose Inhaler (MDI) with spacer
Trial: 26332915
Drug: Immediate PBM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate PBM therapy (2 min treatment using a 4 W laser beam, 171 J delivered)
Trial: 21724005
Drug: Regional intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regional intravenous anesthesia with lidocaine
Trial: 21724005
Drug: Regional intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regional intravenous anesthesia with lidocaine and clonidine
Trial: 16476941
Drug: SIB-1508Y (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SIB-1508Y (10 mg daily)
Trial: 11908373
Drug: Electric toothbrush
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Electric toothbrush (Braun Oral‐B Plaque Remover)
Trial: 8295604
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of DHE 2 mg and paracetamol 1000 mg
Trial: 15054681
Drug: Topical metronidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical metronidazole (10 percent)
Trial: 17184625
Drug: Self-management of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-management of oral anticoagulation
Trial: 1390306
Drug: Low-dose continuous
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose continuous heparin
Trial: 23602777
Drug: Clopidogrel 75
RxNorm normalized name: clopidogrel 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 75 mg daily
Trial: 17407626
Drug: escitalopram 10
RxNorm normalized name: escitalopram 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: escitalopram 10 mg/day
Trial: 31105027
Drug: escitalopram 20
RxNorm normalized name: escitalopram 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: escitalopram 20 mg/day
Trial: 10559616
Drug: Tamsulosin (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin (0.4 mg modified release formulation once daily)
Trial: 1825323
Drug: etodolac 200
RxNorm normalized name: etodolac 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etodolac 200 mg b.i.d.
Trial: 8566633
Drug: naproxen 500
RxNorm normalized name: naproxen 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naproxen 500 mg b.i.d.
Trial: 6836825
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of gentamicin two hours preoperatively
Trial: 6836825
Drug: Three schedules
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three schedules of gentamicin administration
Trial: 30316534
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (50,000 U vitamin D3 pearl weekly for 8 weeks)
Trial: 30016983
Drug: Xiaozhen formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xiaozhen formula and basic treatment
Trial: 30335070
Drug: Basic treatment
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic treatment only
Trial: 21375022
Drug: Routine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine plus mental-regulating acupoints treatment group
Trial: 21375022
Drug: Treatment sessions
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment sessions
Trial: 17634487
Drug: Long-term androgen-deprivation
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term androgen-deprivation therapy (LTAD) plus radiotherapy (RT)
Trial: 16287386
Drug: Mid- and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mid- and late treatment perceptual processing
Trial: 11989834
Drug: Prucalopride 1
RxNorm normalized name: prucalopride 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prucalopride 1 mg
Trial: 11929394
Drug: Prucalopride 1
RxNorm normalized name: prucalopride 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prucalopride 1 mg and 2 mg
Trial: 7545763
Drug: Daily recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily recombinant human growth hormone (rhGH), 0.15 mg/kg IM
Trial: 21413974
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose BoNT‐B (1500 MU)
Trial: 21413974
Drug: Medium dose
RxNorm normalized name: TRIGLYCERIDES,MEDIUM CHAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium dose BoNT‐B (3000 MU)
Trial: 18499270
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate aqueous nasal spray (maintenance therapy)
Trial: 12032514
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no growth hormone treatment)
Trial: 10232715
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg lidocaine 5% intrathecally (group A)
Trial: 10232715
Drug: 0.15 mg
RxNorm normalized name: iodine 0.15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15 mg x kg(‐1) meperidine (group B) co-administered with lidocaine
Trial: 10232715
Drug: 0.30 mg
RxNorm normalized name: Corona Multi-Purpose 0.30 MG/MG Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.30 mg x kg(‐1) meperidine (group C) co-administered with lidocaine
Trial: 6676478
Drug: Physostigmine salicylate
RxNorm normalized name: PHYSOSTIGMINE SALICYLATE
DrugBank: Physostigmine (DB00981)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physostigmine salicylate 0.04 mg kg‐1 BW iv
Trial: 22127555
Drug: Alprazolam administration
RxNorm normalized name: Alprazolam
DrugBank: Alprazolam (DB00404)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alprazolam administration
Trial: 1608114
Drug: Multidrug chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidrug chemotherapy regimens
Trial: 18715415
Drug: Immediate oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate oxytocin administration
Trial: 12202899
Drug: Doxorubicin and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin and paclitaxel (AT combination)